A cannabinoid receptor agonist broadly suppressed inflammatory gene activity in human brain cells
The cannabinoid agonist WIN-55,212-2 robustly inhibited inflammatory gene expression in human astrocytes, working through kinase pathways and neuroprotective transcription factors independently of the CB1 receptor.
Quick Facts
What This Study Found
Transcriptomic analysis showed WIN treatment robustly inhibited the inflammatory response triggered by IL1-beta in human astrocytes. The anti-inflammatory effects were linked to regulation of kinase pathways and gene targets of neuroprotective transcription factors (PPAR and SMAD). Surprisingly, selective CB1 and PPAR antagonists did not block WIN's effects, suggesting alternative receptor involvement.
Key Numbers
WIN treatment induced substantial gene expression changes and robustly inhibited IL1-beta-induced inflammatory response. Effects were dose-dependent but independent of CB1 and PPAR antagonism.
How They Did This
In vitro study using primary human astrocyte cultures. RNA-seq transcriptomic analysis measured gene expression changes after IL1-beta stimulation with and without WIN pretreatment. Dose-response and receptor antagonist experiments conducted with qPCR.
Why This Research Matters
Astrocyte dysfunction drives neuroinflammation in multiple neurodegenerative diseases. Identifying how cannabinoids suppress astrocyte inflammation opens potential therapeutic avenues for conditions like Alzheimer's and MS.
The Bigger Picture
The CB1-independent mechanism suggests that the anti-inflammatory effects of cannabinoids in the brain may work through receptors beyond the classical endocannabinoid system, broadening the potential drug target landscape.
What This Study Doesn't Tell Us
In vitro study with isolated astrocytes. The specific alternative receptor mediating WIN's effects was not identified. WIN is a synthetic agonist, so results may not directly apply to plant cannabinoids.
Questions This Raises
- ?Which alternative receptor(s) mediate WIN's anti-inflammatory effects in astrocytes?
- ?Would plant-derived cannabinoids show the same CB1-independent anti-inflammatory effects?
Trust & Context
- Key Stat:
- Anti-inflammatory effects were CB1-independent in human astrocytes
- Evidence Grade:
- Comprehensive transcriptomic analysis with mechanism exploration, but limited to in vitro astrocyte cultures.
- Study Age:
- Published in 2022.
- Original Title:
- The Cannabinoid Receptor Agonist, WIN-55212-2, Suppresses the Activation of Proinflammatory Genes Induced by Interleukin 1 Beta in Human Astrocytes.
- Published In:
- Cannabis and cannabinoid research, 7(1), 78-92 (2022)
- Authors:
- Fields, Jerel Adam(3), Swinton, Mary K(2), Montilla-Perez, Patricia(3), Ricciardelli, Eugenia, Telese, Francesca
- Database ID:
- RTHC-03839
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How did the cannabinoid reduce inflammation?
WIN suppressed inflammatory gene expression through kinase pathways and neuroprotective transcription factors (PPAR and SMAD), but surprisingly this effect was independent of the CB1 cannabinoid receptor.
What are astrocytes and why do they matter?
Astrocytes are brain support cells that can become harmful when chronically inflamed ("reactive"). They play a crucial role in neuroinflammatory diseases, making them an important therapeutic target.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-03839APA
Fields, Jerel Adam; Swinton, Mary K; Montilla-Perez, Patricia; Ricciardelli, Eugenia; Telese, Francesca. (2022). The Cannabinoid Receptor Agonist, WIN-55212-2, Suppresses the Activation of Proinflammatory Genes Induced by Interleukin 1 Beta in Human Astrocytes.. Cannabis and cannabinoid research, 7(1), 78-92. https://doi.org/10.1089/can.2020.0128
MLA
Fields, Jerel Adam, et al. "The Cannabinoid Receptor Agonist, WIN-55212-2, Suppresses the Activation of Proinflammatory Genes Induced by Interleukin 1 Beta in Human Astrocytes.." Cannabis and cannabinoid research, 2022. https://doi.org/10.1089/can.2020.0128
RethinkTHC
RethinkTHC Research Database. "The Cannabinoid Receptor Agonist, WIN-55212-2, Suppresses th..." RTHC-03839. Retrieved from https://rethinkthc.com/research/fields-2022-the-cannabinoid-receptor-agonist
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.